大森控股(01580.HK)延迟刊发去年业绩 料周四起停牌
大森控股(01580.HK)公布,由於公司需要更多时间获取核数师所要求关於公司建议债务重组程序规定若干详情及若干审计事项的进一步资料,因此将延迟刊发去年年度业绩。董事会承认,延迟刊发去年年度业绩将构成未遵守上市规则。现正就此与核数师进行讨论。董事会及公司管理层一直协助及配合核数师,以於可行情况下尽快加快刊发去年年度业绩。
根据上市规则,若有发行人未能根据上市规则刊发定期财务资料,联交所一般会要求该发行人的证券暂停买卖,直至发行人刊发载有规定财务资料的公告为止。因此,目前预期公司股份将於今年4月1日(本周四)起在联交所暂停买卖,直至公司刊发有关去年年度业绩的公告为止。(ek/a)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.